An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...

The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...

Trastuzumab, tested only as a single agent, has been shown to achieve 7% response in heavily pretreated patients with AOC with 3+ and 2+ HER2 immunostaining by immunohistochemistry (IHC).

This study compared the carbon footprint of SC and IV administration using pertuzumab/trastuzumab as a case example. A Life Cycle Assessment was conducted to compare the environmental impacts of IV ...

That means the biosimilar competitors will be chasing an IV market which represents a relatively ... He said he expects Celltrion's trastuzumab will be up to 50% cheaper than Roche's subcutaneous ...

Alteogen will receive an upfront payment of $20 million, with another $280 million on offer from Daiichi Sankyo if the new formulation of Enhertu (trastuzumab ... versions of IV Enhertu, which ...

Find all the commercial and brand names of generic drug called Trastuzumab. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

The formulations whose retail prices have been fixed include Trastuzumab injection indicated for treatment of metastatic breast cancer and gastric cancer. The regulator has also fixed the prices ...